Leveraging the Influence of Patient Opinion Leaders and Patient Groups
How to build trusted and compliant patient relationships that deliver clinical and commercial insights
The growing influence of Patient Opinion Leaders (POLs) and Patient Advocacy Groups (PAGs) can play a critical role in pharma, from clinical trial design/recruitment to HCP decision-making and regulator/payer support. However, pharma must demonstrate that patient relationships are ethical and compliant with regulations/guidelines. So, what does a good, mutually beneficial patient/pharma relationship look like? In this report, experts explore the challenges and practical solutions that underpin successful pharma/patient engagement.
Companies
GSK, Kyowa Kirin, WEGO Health
- Subject synopsis
- Research methodology and objectives
- Key insights summary
- Issues and insights
- Defining POLs and patient influence
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- The evolving role of POLs
- Issue summary
- Questions
- Key insights
- Supporting quotes
- The impact of POLs and PAGs on the pharmaceutical industry
- Issue summary
- Questions
- Key insights
- Supporting quotes
- The benefits and challenges of engaging POLs and PAGs
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Mutually beneficial interactions
- Issue summary
- Questions
- Key insights
- Supporting quotes
- The future role of POL and PAG influence
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Ensuring successful interactions with POLs and PAGs
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook